A Randomised Phase III Clinical Trial Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Collaborating Groups
Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
Related Post
6 November, 2025
SUPREMO trial findings signal change in breast cancer treatment
LATEST NEWS: 6 November 2025 Radiotherapy can be safely
23 October, 2025
TROG collaboration sees international skin cancer trial open in Australia
LATEST NEWS: 23 October 2025 TROG Cancer Research has